EK International Hospital Thailand (stock code: EKH) was established in Bangkok in 2004. With comprehensive facilities, strong medical expertise, a complete service system and a good industry reputation, it was listed on Thailand's main stock exchange in 2016.

As an international general hospital, EK International Hospital can also help patients obtain medical visa exemptions during exceptional circumstances, facilitating efficient entry into Thailand through a special channel.

EKI Assisted Reproduction Research Center is a core department of EK International Hospital and has received multiple honors from the Royal Thai College of Obstetricians and Gynaecologists. It addresses infertility and assisted reproduction needs while treating related gynecological conditions to support overall IVF outcomes.

EKI Assisted Reproduction Research Center has been a core department focused on IVF research since EK International Hospital was established in 2004.

The center has a nationally recognized fertility team led by medical doctors, along with internationally standardized fertility equipment and an IVF laboratory. It also benefits from the comprehensive service system of a listed general hospital, providing high-quality, comprehensive IVF care.

The medical team is experienced in third-generation IVF, including preimplantation genetic testing. This technology is used to reduce the likelihood of transferring embryos with disease-causing genetic variants or chromosomal abnormalities. Based on individualized fertility plans, selected embryos can be transferred to support treatment outcomes.

Patients with diverse backgrounds and conditions travel from around the world to EKI Assisted Reproduction Research Center. Years of dedicated service and many successful cases have given EK International Hospital international recognition and a strong reputation among patients pursuing fertility treatment.